Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients

Oral Oncology

Volumn 54, Issue , 2016, Pages 36-41

  Mazurek, Agnieszka M ^a   Rutkowski, Tomasz ^a   Fiszer Kierzkowska, Anna ^a   Małusecka, Ewa ^a   Składowski, Krzysztof ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Circulating cell free DNA; EGFR; Head and neck cancer; HPV; Human papillomavirus; KRAS; Oropharyngeal cancer; Plasma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; VIRUS DNA; KRAS PROTEIN, HUMAN; PROTEIN P21; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SOMATIC MUTATION; VIRUS DETECTION; BLOOD; EARLY CANCER DIAGNOSIS; GENETICS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PROCEDURES; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; VIROLOGY; YOUNG ADULT;

ADULT; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; GENES, ERBB-1; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS P21(RAS); YOUNG ADULT;

EID: 84960503648     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.12.002     Document Type: Article

References (50)

1. E.J. Verweij, J.M. van den Oever, M.A. de Boer, E.M. Boon, and D. Oepkes Diagnostic accuracy of noninvasive detection of fetal trisomy 21 in maternal blood: a systematic review Fetal Diagn Ther 31 2012 81 86
2. A.B. Sparks, E.T. Wang, C.A. Struble, W. Barrett, R. Stokowski, C. McBride, and et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy Prenat Diagn 32 2012 3 9
3. T.M. Snyder, K.K. Khush, H.A. Valantine, and S.R. Quake Universal noninvasive detection of solid organ transplant rejection Proc Natl Acad Sci USA 108 2011 6229 6234
4. P.A. Ascierto, D. Minor, A. Ribas, C. Lebbe, A. O'Hagan, N. Arya, and et al. Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma J Clin Oncol 31 2013 3205 3211
5. A. Mazurek, M. Pierzyna, M. Giglok, U. Dworzecka, R. Suwiński, and E. Małusecka Quantification of concentration and assessment of EGFR mutation in circulating DNA Cancer Biomark 15 2015 515 524
6. E. Crowley, F. Di Nicolantonio, F. Loupakis, and A. Bardelli Liquid biopsy: monitoring cancer-genetics in the blood Nat Rev Clin Oncol 10 2013 472 484
7. R. Lebofsky, C. Decraene, V. Bernard, M. Kamal, A. Blin, Q. Leroy, and et al. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types Mol Oncol 9 2015 783 790
8. E. Kidess, and S.S. Jeffrey Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis? Genome Med 5 2013 e70
9. M. Fleischhacker, and B. Schmidt Circulating nucleic acids (CNAs) and cancer - a survey Biochim Biophys Acta 1775 2007 181 232
10. C. Bettegowda, M. Sausen, R.J. Leary, I. Kinde, Y. Wang, N. Agrawal, and et al. Detection of circulating tumor DNA in early- and late-stage human malignancies Sci Transl Med 6 2014 224ra24
11. S. Jahr, H. Hentze, S. Englisch, D. Hardt, F.O. Fackelmayer, R.D. Hesch, and et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res 61 2001 1659 1665
12. E. Gormally, E. Caboux, P. Vineis, and P. Hainaut Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance Mutat Res 635 2007 105 117
13. B. Gold, M. Cankovic, L.V. Furtado, F. Meier, and C.D. Gocke Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology J Mol Diagn 17 2015 209 224
14. K. Jung, M. Fleischhacker, and A. Rabien Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature Clin Chim Acta 411 2010 1611 1624
15. Y.I. Elshimali, H. Khaddour, M. Sarkissyan, Y. Wu, and J.V. Vadgama The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients Int J Mol Sci 14 2013 18925 18958
16. B.K. Thakur, H. Zhang, A. Becker, I. Matei, Y. Huang, B. Costa-Silva, and et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection Cell Res 24 2014 766 769
17. D. García-Olmo, D.C. García-Olmo, J. Ontañón, and E. Martinez Horizontal transfer of DNA and the "genometastasis hypothesis" Blood 95 2000 724 725
18. P. Pinzani, F. Salvianti, M. Pazzagli, and C. Orlando Circulating nucleic acids in cancer and pregnancy Methods 50 2010 302 307
19. C.J. Langer Exploring biomarkers in head and neck cancer Cancer 118 2012 3882 3892
20. A.M. Egloff, J.W. Lee, C.J. Langer, H. Quon, A. Vaezi, J.R. Grandis, and et al. Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: eastern cooperative oncology group trial E3303 Clin Cancer Res 20 2014 5041 5051
21. H.J. Wanebo, J. Lee, B.A. Burtness, J.A. Ridge, M. Ghebremichael, S.A. Spencer, and et al. Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303) Ann Oncol 25 2014 2036 2041
22. J.R. Hecht, J.Y. Douillard, L. Schwartzberg, A. Grothey, S. Kopetz, A. Rong, and et al. Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer Cancer Treat Rev 41 2015 653 659
23. K. Warton, and G. Samimi Methylation of cell-free circulating DNA in the diagnosis of cancer Front Mol Biosci 2 2015 e13
24. A.M. Mazurek, A. Fiszer-Kierzkowska, T. Rutkowski, K. Składowski, M. Pierzyna, D. Scieglińska, and et al. Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma Cancer Biomark 13 2013 385 394
25. M. Lindh, S. Görander, E. Andersson, P. Horal, I. Mattsby-Balzer, and W. Ryd Real-time Taqman PCR targeting 14 human papilloma virus types J Clin Virol 40 2007 321 324
26. V. Kotoula, E. Charalambous, B. Biesmans, A. Malousi, E. Vrettou, G. Fountzilas, and et al. Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics PLoS One 4 2009 e7746
27. K. Endo, A. Konishi, H. Sasaki, M. Takada, H. Tanaka, M. Okumura, and et al. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay Lung Cancer 50 2005 375 384
28. L. Wang, J.C. Soria, B.L. Kemp, D.D. Liu, L. Mao, and F.R. Khuri HTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer Clin Cancer Res 8 2002 2883 2889
29. G. Sozzi, D. Conte, M. Leon, R. Ciricione, L. Roz, C. Ratcliffe, and et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer J Clin Oncol 21 2003 3902 3908
30. A.S. Devonshire, A.S. Whale, A. Gutteridge, G. Jones, S. Cowen, C.A. Foy, and et al. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification Anal Bioanal Chem 406 2014 6499 6512
31. C. Kohler, Z. Barekati, R. Radpour, and X.Y. Zhong Cell-free DNA in the circulation as a potential cancer biomarker Anticancer Res 31 2011 2623 2628
32. D. Hashad, A. Sorour, A. Ghazal, and I. Talaat Free circulating tumor DNA as a diagnostic marker for breast cancer J Clin Lab Anal 26 2012 467 472
33. R. Agassi, D. Czeiger, G. Shaked, A. Avriel, J. Sheynin, K. Lavrenkov, and et al. Measurement of circulating cell-free DNA levels by a simple fluorescent test in patients with breast cancer Am J Clin Pathol 143 2015 18 24
34. K. Kim, D.G. Shin, M.K. Park, S.H. Baik, T.H. Kim, S. Kim, and et al. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection Ann Surg Treat Res 86 2014 136 142
35. J. Jylhävä, T. Nevalainen, S. Marttila, M. Jylhä, A. Hervonen, and M. Hurme Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty Aging Cell 12 2013 388 397
36. Y. Kuratomi, K. Kusano, R. Shimazu, and A. Inokuchi Innate immune reactions in locally limited tonsillar cancer Eur Arch Otorhinolaryngol 270 2013 2751 2758
37. J. Jylhävä, M. Jylhä, T. Lehtimäki, A. Hervonen, and M. Hurme Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the vitality 90+ study Exp Gerontol 47 2012 372 378
38. M. Staub, and F. Antoni Excretion of newly synthesized DNA by tonsil lymphocytes Nucleic Acids Res 5 1978 3071 3079
39. A.A. Kamat, F.Z. Bischoff, D. Dang, M.F. Baldwin, L.Y. Han, Y.G. Lin, and et al. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma Cancer Biol Ther 5 2006 1369 1374
40. L.L. Swystun, S. Mukherjee, and P.C. Liaw Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus J Thromb Haemost 9 2011 2313 2321
41. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, L. Wu, and et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
42. D.J. Haraf, E. Nodzenski, D. Brachman, R. Mick, A. Montag, D. Graves, and et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival Clin Cancer Res 2 1996 755 762
43. E. Ringström, E. Peters, M. Hasegawa, M. Posner, M. Liu, and K.T. Kelsey Human papillomavirus type 16 and squamous cell carcinoma of the head and neck Clin Cancer Res 8 2002 3187 3192
44. H. Cao, A. Banh, S. Kwok, X. Shi, S. Wu, T. Krakow, and et al. Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients Int J Radiat Oncol Biol Phys 82 2012 e351 e358
45. N.C. Olthof, C.U. Huebbers, J. Kolligs, M. Henfling, F.C. Ramaekers, I. Cornet, and et al. Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines Int J Cancer 136 2015 E207 E218
46. E. Bissada, O. Abboud, Z. Abou Chacra, L. Guertin, X. Weng, P.F. Nguyen-Tan, and et al. Prevalence of K-RAS Codons 12 and 13 mutations in locally advanced head and neck squamous cell carcinoma and impact on clinical outcomes Int J Otolaryngol 2013 2013 848021
47. B. Szabó, G.A. Nelhubel, A. Kárpáti, I. Kenessey, B. Jóri, C. Székely, and et al. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas Oral Oncol 47 2011 487 496
48. H. Li, J.S. Wawrose, W.E. Gooding, L.A. Garraway, V.W. Lui, N.D. Peyser, and et al. Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection Mol Cancer Res 12 2014 571 582
49. N. Stransky, A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, A. Sivachenko, and et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
50. N. Agrawal, M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, R.J. Li, and et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157